Brooklyn Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.81M Buy
135,740
+45,677
+51% +$1.22M 0.12% 133
2025
Q4
$2.25M Buy
90,063
+31,989
+55% +$807K 0.1% 159
2025
Q3
$1.4M Sell
58,074
-669
-1% -$16.5K 0.19% 107
2025
Q2
$1.42M Buy
58,743
+42,723
+267% +$996K 0.19% 105
2025
Q1
$406K Buy
16,020
+3,283
+26% +$85.9K 0.09% 201
2024
Q4
$338K Sell
12,737
-33,932
-73% -$920K 0.1% 166
2024
Q3
$1.35M Buy
46,669
+11,804
+34% +$344K 0.44% 40
2024
Q2
$966K Hold
34,865
0.42% 53
2024
Q1
$966K Buy
34,865
+18,380
+111% +$510K 0.42% 53
2023
Q4
$475K Buy
+16,485
New +$498K 0.23% 101

Other funds holding PFE

Brooklyn Investment Group's PFE Position: Q1 2026 in Review

Brooklyn Investment Group increased its Pfizer (PFE) stake by 51% in Q1 2026, buying an estimated $1.22M and bringing the position to 135,740 shares worth $3.81M. The position accounts for 0.12% of the portfolio, ranked #133.

Brooklyn Investment Group first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Brooklyn Investment Group held 135,740 shares of Pfizer worth $3.81M as of Q1 2026.
  • Brooklyn Investment Group bought 45,677 Pfizer shares in Q1 2026, an estimated $1.22M.
  • Pfizer made up 0.12% of Brooklyn Investment Group's portfolio in Q1 2026, its #133 holding.
  • Brooklyn Investment Group first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.